BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Clinical Outcome
51 results:

  • 1. Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.
    Roller A; Davydov II; Schwalie PC; Serrano-Serrano ML; Heller A; Staedler N; Ferreira CS; Dietmann G; Klaman I; Valdeolivas A; Korski K; Cannarile MA
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38649280
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparison of Baseline
    Wu M; Wang Y; Yang Q; Wang X; Yang X; Xing H; Sang X; Li X; Zhao H; Huo L
    J Nucl Med; 2023 Oct; 64(10):1532-1539. PubMed ID: 37500263
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment.
    Xiong Y; Cao P; Lei X; Tang W; Ding C; Qi S; Chen G
    World J Surg Oncol; 2022 Sep; 20(1):328. PubMed ID: 36180867
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
    Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
    [No Abstract]    [Full Text] [Related]  

  • 5. Impact of Modern Management Strategies on the clinical outcome of Patients With Low Rectal cancer - A Retrospective, Monocentric Cohort Study.
    Karam E; Sindayigaya R; Giger-Pabst U; Gabriel M; Michot N; Courtot L; Tabchouri N; Moussata D; Lecomte T; Chapet S; Calais G; Bourlier P; Salamé E; Ouaissi M
    Anticancer Res; 2022 Apr; 42(4):1949-1963. PubMed ID: 35347015
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study.
    Wagner NB; Lenders MM; Kühl K; Reinhardt L; André F; Dudda M; Ring N; Ebel C; Stäger R; Zellweger C; Lang R; Paar M; Gussek P; Richtig G; Stürmer SH; Kimeswenger S; Oellinger A; Forschner A; Leiter U; Weide B; Gassenmaier M; Schraag A; Klumpp B; Hoetzenecker W; Berking C; Richtig E; Ziemer M; Mangana J; Terheyden P; Loquai C; Nguyen VA; Gebhardt C; Meier F; Diem S; Cozzio A; Flatz L; Röcken M; Garbe C; Eigentler TK
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33986126
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Simultaneous Stereotactic Radiofrequency Ablation of Multiple (≥ 4) liver Tumors: Feasibility, Safety, and Efficacy.
    Schullian P; Putzer D; Eberle G; Laimer G; Bale R
    J Vasc Interv Radiol; 2020 Jun; 31(6):943-952. PubMed ID: 32414570
    [TBL] [Abstract] [Full Text] [Related]  

  • 9.
    Wong A; Callahan J; Keyaerts M; Neyns B; Mangana J; Aberle S; Herschtal A; Fullerton S; Milne D; Iravani A; McArthur GA; Hicks RJ
    Cancer Imaging; 2020 May; 20(1):36. PubMed ID: 32408884
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases.
    Stremitzer S; Vermeulen P; Graver S; Kockx M; Dirix L; Yang D; Zhang W; Stift J; Wrba F; Gruenberger T; Lenz HJ; Scherer SJ
    Br J Cancer; 2020 May; 122(10):1518-1524. PubMed ID: 32205863
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis.
    Li X; Liu L; Hu Y
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32162652
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Reduced Risk of Sinusoidal Obstruction Syndrome of the liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation.
    El-Serafi I; Remberger M; Ringdèn O; Törlén J; Sundin M; Björklund A; Winiarski J; Mattsson J
    Clin Transl Sci; 2020 Mar; 13(2):293-300. PubMed ID: 31675173
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir.
    Brancaccio G; Fasano M; Grossi A; Santantonio TA; Gaeta GB
    Aliment Pharmacol Ther; 2019 Apr; 49(8):1071-1076. PubMed ID: 30793345
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. clinical outcome after resection of early-stage hilar cholangiocarcinoma.
    Stremitzer S; Jones RP; Quinn LM; Fenwick SW; Diaz-Nieto R; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2019 Feb; 45(2):213-217. PubMed ID: 30360988
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Gastrointestinal Stromal Tumors: A Clinicopathological and Immunohistochemical Study of 65 Cases.
    Tepeoğlu M; Özgün G; Tunca MZ; Tezcaner T; Özdemir BH
    Turk Patoloji Derg; 2018; 34(3):207-214. PubMed ID: 29630088
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN).
    Wranke A; Pinheiro Borzacov LM; Parana R; Lobato C; Hamid S; Ceausu E; Dalekos GN; Rizzetto M; Turcanu A; Niro GA; Lubna F; Abbas M; Ingiliz P; Buti M; Ferenci P; Vanwolleghem T; Hayden T; Dashdorj N; Motoc A; Cornberg M; Abbas Z; Yurdaydin C; Manns MP; Wedemeyer H; Hardtke S;
    Liver Int; 2018 May; 38(5):842-850. PubMed ID: 28963781
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mesohepatectomy Versus Extended Hemihepatectomies for Centrally Located liver Tumors: A Meta-Analysis.
    Li J; Wang C; Song J; Chen N; Jiang L; Yang J; Yan L
    Sci Rep; 2017 Aug; 7(1):9329. PubMed ID: 28839257
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
    Suenaga M; Schirripa M; Cao S; Zhang W; Yang D; Murgioni S; Rossini D; Marmorino F; Mennitto A; Ning Y; Okazaki S; Berger MD; Miyamoto Y; Gopez R; Barzi A; Yamaguchi T; Loupakis F; Lenz HJ
    Ann Oncol; 2017 May; 28(5):1015-1022. PubMed ID: 28453695
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy does not affect future liver remnant growth and outcomes of associating liver partition and portal vein ligation for staged hepatectomy.
    Hasselgren K; Malagò M; Vyas S; Campos RR; Brusadin R; Linecker M; Petrowsky H; Clavien PA; Machado MA; Hernandez-Alejandro R; Wanis K; Valter L; Sandström P; Björnsson B
    Surgery; 2017 May; 161(5):1255-1265. PubMed ID: 28081953
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Enucleation versus hepatectomy for giant hepatic haemangiomas: a meta-analysis.
    Cheng WL; Qi YQ; Wang B; Tian L; Huang W; Chen Y
    Ann R Coll Surg Engl; 2017 Mar; 99(3):237-241. PubMed ID: 27869486
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.